Sign in

CIK 0001737287 · Non-accelerated filer<br>Smaller reporting company

Allogene Therapeutics, Inc.

Sign in to watch
Ticker
ALLO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
823562771
Phone
(650) 457-2700
Business address
210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Open-market sale SVP, Finance sold 9,586 shares at $2.31 ($22,144)
  2. 144 Insider Sale of Securities
  3. PRE 14A Proxy Proxy Statement (Preliminary)
  4. 8-K Event Other events
  5. 424B5 Offering Prospectus
  6. 424B5 Offering Prospectus
  7. 8-K Event Other events
  8. 8-K Event Other events
  9. 4 Open-market sale SVP, Chief Technical Officer sold 2,867 shares at $2.50 ($7,168)
  10. 144 Insider Sale of Securities
  11. 4 Open-market sale SVP, Chief Technical Officer sold 4,835 shares at $2.47 ($11,942)
  12. 4 Open-market sale President and CEO sold 47,763 shares at $2.47 ($117,975)
  13. 144 Insider Sale of Securities
  14. 144 Insider Sale of Securities
  15. S-8 Other Securities Offered to Employees in Benefit Plans
  16. 10-K Report Annual Report
  17. 8-K Event Results of operations
  18. 4 Open-market sale SVP, Chief Technical Officer sold 7,132 shares at $2.60 ($18,543)
  19. 144 Insider Sale of Securities
  20. SCHEDULE 13G/A Stake Statement of Beneficial Ownership

Page 3 of 30 · 587 filings